Conference Paper: Self efficacy predicts adherence to continuous positive airway pressure therapy in obstructive sleep apnea

File Download Links for fulltext
(May Require Subscription)
  • Find via
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleSelf efficacy predicts adherence to continuous positive airway pressure therapy in obstructive sleep apnea
AuthorsLai, AYK
Lam, JCM
Svikis, DP
Fong, DYT
Ip, MSM
Issue Date2012
PublisherAmerican Thoracic Society. The Journal's web site is located at http://ajrccm.atsjournals.org
CitationAmerican Thoracic Society International Conference, San Francisco, CA., 18-23 May 2012, Meeting Abstracts, p. A3846 [How to Cite?]
AbstractIntroduction: Continuous positive airway pressure (CPAP) therapy is the standard treatment for obstructive sleep apnea (OSA). However, low CPAP adherence limits its treatment effectiveness, and it has been recognized as a contributing factor to poor physiological and psychosocial health in untreated or under-treated OSA patients. This study investigated the relationships between CPAP adherence, biomedical and cognitive factors in subjects with OSA. Methods: Subjects who were newly diagnosed of OSA and CPAP therapy naïve were recruited. Their demographic, anthropometric and physiological data were obtained after the in-laboratory sleep studies. They filled in Self Efficacy Measure for Sleep Apnea (SEMSA) questionnaire (measuring cognitive perception of risk, outcome expectancies and self-efficacy) in addition to the Epworth Sleepiness Scale (ESS). Fixed CPAP pressure was prescribed after in-laboratory titration as indicated. CPAP adherence was objectively measured at 1 and 4 weeks after CPAP use. Results: 91 subjects (14 females) were evaluated, with mean ± SD age of 52 ± 9 years, body mass index (BMI) of 29 ± 5.6 kg/m2, ESS score of 9 ± 5, apnea-hypopnea index (AHI) of 28.7 (21, 53) /hr. Mean days of CPAP use (>= 4hrs/day) in 1 and 4 weeks were 3.9 ± 2.7 days and 18.9 ± 9.5 days, respectively. On univariate analysis, there were no significant associations between CPAP adherence and clinical parameters (age, gender, BMI, sleep parameters), prescribed CPAP pressure and sleepiness. Self-efficacy score of cognitive perception measured before the start of CPAP therapy was associated with CPAP use in 1 week (ß=1.272 (0.556, 1.987)) and 4 weeks (ß= 4.163 (1.462, 6.863)), but not risk perception and outcome expectancies. Multiple linear analysis showed self-efficacy score is a significant predictor of CPAP adherence at 1 and 4 weeks after adjusting for age, gender and OSA severity. Conclusions: Self efficacy score of cognitive perception is a significant predictor of adherence to CPAP therapy in OSA.
ISSN1073-449X
2011 Impact Factor: 11.08
2011 SCImago Journal Rankings: 1.008
DC Field
Value
dc.contributor.authorLai, AYK
dc.contributor.authorLam, JCM
dc.contributor.authorSvikis, DP
dc.contributor.authorFong, DYT
dc.contributor.authorIp, MSM
dc.date.accessioned2012-09-20T08:18:11Z
dc.date.available2012-09-20T08:18:11Z
dc.date.issued2012
dc.description.abstractIntroduction: Continuous positive airway pressure (CPAP) therapy is the standard treatment for obstructive sleep apnea (OSA). However, low CPAP adherence limits its treatment effectiveness, and it has been recognized as a contributing factor to poor physiological and psychosocial health in untreated or under-treated OSA patients. This study investigated the relationships between CPAP adherence, biomedical and cognitive factors in subjects with OSA. Methods: Subjects who were newly diagnosed of OSA and CPAP therapy naïve were recruited. Their demographic, anthropometric and physiological data were obtained after the in-laboratory sleep studies. They filled in Self Efficacy Measure for Sleep Apnea (SEMSA) questionnaire (measuring cognitive perception of risk, outcome expectancies and self-efficacy) in addition to the Epworth Sleepiness Scale (ESS). Fixed CPAP pressure was prescribed after in-laboratory titration as indicated. CPAP adherence was objectively measured at 1 and 4 weeks after CPAP use. Results: 91 subjects (14 females) were evaluated, with mean ± SD age of 52 ± 9 years, body mass index (BMI) of 29 ± 5.6 kg/m2, ESS score of 9 ± 5, apnea-hypopnea index (AHI) of 28.7 (21, 53) /hr. Mean days of CPAP use (>= 4hrs/day) in 1 and 4 weeks were 3.9 ± 2.7 days and 18.9 ± 9.5 days, respectively. On univariate analysis, there were no significant associations between CPAP adherence and clinical parameters (age, gender, BMI, sleep parameters), prescribed CPAP pressure and sleepiness. Self-efficacy score of cognitive perception measured before the start of CPAP therapy was associated with CPAP use in 1 week (ß=1.272 (0.556, 1.987)) and 4 weeks (ß= 4.163 (1.462, 6.863)), but not risk perception and outcome expectancies. Multiple linear analysis showed self-efficacy score is a significant predictor of CPAP adherence at 1 and 4 weeks after adjusting for age, gender and OSA severity. Conclusions: Self efficacy score of cognitive perception is a significant predictor of adherence to CPAP therapy in OSA.
dc.identifier.citationAmerican Thoracic Society International Conference, San Francisco, CA., 18-23 May 2012, Meeting Abstracts, p. A3846 [How to Cite?]
dc.identifier.epageA3846
dc.identifier.hkuros207019
dc.identifier.issn1073-449X
2011 Impact Factor: 11.08
2011 SCImago Journal Rankings: 1.008
dc.identifier.openurl
dc.identifier.spageA3846
dc.identifier.urihttp://hdl.handle.net/10722/165425
dc.identifier.volumeMeeting Abstracts
dc.languageeng
dc.publisherAmerican Thoracic Society. The Journal's web site is located at http://ajrccm.atsjournals.org
dc.relation.ispartofAmerican Journal of Respiratory and Critical Care Medicine
dc.titleSelf efficacy predicts adherence to continuous positive airway pressure therapy in obstructive sleep apnea
dc.typeConference_Paper